Spotlight Center on HIV Prevention Today

New Approach to HIV Microbicide Development

January 8, 2013

Journal PLoS reports a French-led international research team has demonstrated success blocking transmission of SHIV (a simian analogue to human HIV) in macaque monkeys, using a vaginal gel containing microproteins that mimic the CD4 receptor structure on the outer shells of CD4 immune cells. The study authors write, "These results demonstrate that M48U1 miniCD4 acts in vivo as a potent entry inhibitor, which may be considered in microbicide developments."

BBC, reporting on this and other developments, welcomed the report but cautioned that safe sex with condoms will be necessary until there is either an effective HIV vaccine or a cure. provides a solid, non-specialist-friendly summary of the study results and underlying science.

This article was provided by National Association of People With AIDS. It is a part of the publication Positive Voice.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.